Speaker To Be Announced

Company: Natera
Seminars:
Informed By The Tumor: The Power of a Personalized ctDNA Assay For MRD Detection & Monitoring in NSCLC 3:30 pm
Latest clinical data from 2022 publications and presentations Advantages of a personalized, tumor-informed ctDNA assay for molecular residual disease detection Applications of Signatera in clinical trial design to maximize trial success, and accelerate time to data readoutRead more
day: Day One